Skip to content
Screener

Merck & Co. MRK Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

Arcus Biosciences logo
Arcus BiosciencesRCUS
$0
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Summit Therapeutics logo
Summit TherapeuticsSMMT
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE

Other financials

Income statement

See full
Revenue$16.6B+5.1%
Gross profit$12.2B-0.3%
Net income-$1.3B-130%
EPS (diluted)-$0.54-131%

Balance sheet

See full
Cash & equivalents$6.9B-14.6%
Total debt$56.7B+54.0%
Total equity$41.9B-14.4%
Total assets$129.80B+10.4%

Cash flow

See full
Operating cash flow$5.4B+63.1%
CapEx$893.0M+16.9%
Free cash flow$4.5B+77.0%

Valuation

See full
Market cap$323B+60.3%
Enterprise value$372.84B+61.9%
P/E101.8×+89.5×
P/S4.9×+1.7×

Profitability

See full
Gross margin73%-3.6pp
Net margin4.8%-21.0pp
FCF margin24.1%+1.0pp

Returns & leverage

See full
Return on equity7%-28.5pp
Debt / equity1.4×+0.6×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:11 PM EDT
Fiscal quarter
Q3 FY2028
Calendar quarter
Q3 2028
Accession
0000310158-26-000212
($ in millions)June 30, 2026 / Amortized CostJune 30, 2026 / Gross Unrealized / GainsJune 30, 2026 / Gross Unrealized / LossesJune 30, 2026 / Fair ValueDecember 31, 2025 / Amortized CostDecember 31, 2025 / Gross Unrealized / GainsDecember 31, 2025 / Gross Unrealized / LossesDecember 31, 2025 / Fair Value
Commercial paper$292$292
Foreign government bonds11
U.S. government and agency securities100100
Total debt securities$292$292$101$101
Publicly traded equity securities (1)1,2741,392
Total debt and publicly traded equity securities$1,566$1,493

Item 1. Financial Statements

FAQ

What is Merck & Co.'s unrealized gains on investments?
Merck & Co. (MRK) reported unrealized gains on investments of $0 in Q2 2026.
What does unrealized gains on investments mean?
This reflects the cumulative positive change in the fair value of available-for-sale securities that have not yet been sold. These gains are recognized in equity as part of accumulated other comprehensive income.

Ask your AI about Merck & Co.'s unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude